GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea
GSK is counting on new infectious disease treatments, such as its recently launched respiratory syncytial virus vaccine, to help offset revenue losses from its top-selling drugs and anticipated patent expirations for its HIV therapies.
The drug gepotidacin has already been approved in the United States under the brand name Blujepa for a common type of urinary tract infection (UTI) in women and adolescent girls.
The FDA's decision on the drug's treatment of uncomplicated urogenital gonorrhoea is expected in December. If approved, it would provide an oral option to patients who currently rely on injectable treatments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
10 minutes ago
- Daily Mail
Warning as woman, 27, suffers horrifying reaction to one of UK's most taken pain medications - skin 'fell off in sheets'
A mother-of-three has told of her horrifying ordeal after she was put in a 21-day coma after suffering a rare reaction to ibuprofen that caused her skin to 'fall off in sheets.' Aleshia Rogers, 27, from Nebraska, took two of the over-the-counter tablets a day in August 2020 following the birth of her son Jaxon via c-section. The young mother had been taking ibuprofen, which she described as her 'go-to med', for years to help relieve her period cramps. However, after three weeks of taking the painkiller, she started suffering flu-like symptoms including a fever and a burning sensation when she swallowed. She also noticed a rash on her chest and her eyes beginning to swell. 'They were bloodshot and burning so I went to the ER where they told me I had pink eye and sent me home,' the child and education technician recalled. But the next day whole face was swollen, making it difficult to breathe. 'The next day both my eyes were swollen shut so I went back to the ER. They told me I had scarlet fever and to go home.' She said she was also advised to carry on taking the painkiller to alleviate her pain and reduce the swelling. Within hours, her symptoms rapidly escalated and she developed burning blisters across her face, eyes and chest causing her skin to peel off. She rushed to the hospital once again where she was eventually diagnosed with Stevens-Johnson syndrome (SJS) and later toxic epidermal necrolysis—which doctors suspected was triggered by the ibuprofen. As her condition rapidly deteriorated and she developed sepsis and multiple organ failure, doctors put her in a coma—which she wouldn't wake up from for three weeks. At this point, the mother-of-three had lost around 95 per cent of her skin, causing her to into organ failure. Her family were told she had just a 10 per cent chance of surviving the ordeal. The rare skin condition causes the immune system to overreact to a trigger, in this case ibuprofen, and attack healthy skin, the eyelids and genitals. Five years on, Ms Rogers is still recovering from long-term complications associated with SJS. Recalling the moment she woke up from the coma she said: 'The doctors told me my skin had died and detached. 'They called it sloughing. It fell off in sheets. But I had absolutely no idea what had happened to me,' she added. 'I even forgot that I had given birth. I lost a lot of memories. 'My family told me it really was touch and go as to whether I'd make it through. I've been told so many times I'm a miracle so I try and live my life like tomorrow isn't promised and try not to live in fear.' Now, the young mother is determined to raise better awareness for the life-threatening condition and remind people that all drugs come with a risk. 'We believe it was all triggered by taking ibuprofen,' she explained. 'There's no prevention [for the condition] and once it starts, there's nothing you can do to stop it. There's also a chance I can get it again at any time. 'I don't want people to be afraid of medicines, but I want people to be aware and mindful of what can happen.' Ms Rogers is not believed to have suffered an adverse reaction to ibuprofen before with doctors unable to say for sure why the reaction occurred. SJS often begins with flu-like symptoms, including a high temperature, sore throat and joint pain, followed by a red or purple rash that usually starts on the upper body before spreading to the face, arms, legs and other areas of the body. Blister will then appear on the skin, which burst to leave painful sores. The same happens inside the body, primarily affecting the mucous membranes—the soft layers of tissue which line the digestive system, inside of the nose and mouth and the genitals. Without treatment, the condition can be life-threatening with studies suggesting around one in 10 cases are fatal. Hospital treatment, which is usually carried out in an intensive care unit, usually involves fluids to prevent dehydration, creams and dressings to moisturise the skin, and strong painkillers to ease discomfort and control inflammation. Some patients will also be placed into a medically induced coma to minimise damage and further stress on the body. In cases where symptoms were triggered by a reaction to a medicine, patients will have to avoid the treatment for the rest of their life. In the last year, nine people have been rushed to hospital in Singapore after taking 'energy boosting' pills which triggered the agonising skin conditions. The seven men and two women had all taken modafinil or armodafinil—prescription only drugs designed to treat narcolepsy, a condition that impairs a person's ability to sleep or stay awake. Only modafinil is licensed for clinical use in the UK, where all patients have to be monitored regularly due to the risk side effects. Despite this, the drug has gained popularity among recreational users—including students who use it to help them stay awake while cramming for exams. Six of the patients developed Stevens-Johnson syndrome (SJS), a life-threatening skin reaction characterised by blistering and severe peeling of the skin. The other three suffered toxic epidermal necrolysis, a more severe form of SJS.
Reuters
2 hours ago
- Reuters
IO Biotech's cancer vaccine shows improvement in late-stage study goal
Aug 11 (Reuters) - IO Biotech (IOBT.O), opens new tab said on Monday its experimental cancer vaccine, in combination with Merck's (MRK.N), opens new tab Keytruda, showed improvement in a late-stage study goal, but was not statistically significant. It was testing the vaccine in 407 patients with advanced skin cancer. The company said it plans to meet with the U.S. Food and Drug Administration this fall to discuss the data and next steps for a potential regulatory submission.
Medical News Today
2 hours ago
- Medical News Today
What to know about post-traumatic stress disorder (PTSD) and migraine
Research indicates there is a link between PTSD and migraine. However, research is limited, and scientists are still learning about the relationship between the conditions. The use of binary terms such as 'male' and 'female' or 'men' and 'women' in this article reflects the language of the sources we've used. Unless otherwise noted, it's unclear whether the research we reference included participants with expansive gender do not know whether migraine contributes to the development of PTSD or PTSD contributes to the development of migraine. A 2016 review of research found that PTSD symptoms were associated with a higher likelihood of experiencing frequent headaches or migraine episodes. The review authors also noted that individuals with PTSD who are experiencing intrusive reminders of a traumatic event may be most affected by migraine episodes or headaches.A 2017 study involving pregnant women found that the likelihood of experiencing PTSD is increased in individuals with migraine. The study authors suggested that PTSD screening could be beneficial for pregnant women with migraine.A 2011 review noted that one of the possible mechanisms linking migraine and PTSD could be a dysfunction between the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. The hypothalamic-pituitary-adrenal axis regulates the autonomic nervous system and manages the stress response. The autonomic nervous system consists of the sympathetic and parasympathetic nervous systems. The sympathetic nervous system activates when the body is exposed to stressful stimuli, resulting in the fight, flight, or freeze the review authors highlighted that further research into the relationship between PTSD and migraine is who suspects they are experiencing PTSD or migraine should contact a healthcare professional. A doctor can make an accurate diagnosis and recommend appropriate treatment, if necessary. Learn more about PTSD17 symptoms of PTSD explainedTypes of PTSDRelationships and PTSD: What to knowPTSS vs. PTSD: What are the differences?
